Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice

Ayo A. Toye; Marc‐Emmanuel Dumas; Christine Blancher; Alice Rothwell; Jane Fearnside

doi:10.1007/s00125-007-0738-5

Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice

Ayo A. Toye, Marc‐Emmanuel Dumas, Christine Blancher, Alice Rothwell, Jane Fearnside, Steven P. Wilder, M.-T. Bihoreau, Olivier Cloarec, Imane Azzouzi, Stephen G. Young, Richard H. Barton, Elaine Holmes, Mark I. McCarthy, Roger Tatoud, Jeremy K. Nicholson...

Springer Science+Business Media (2007) • Volume 50, Issue 9, Pages 1867-1879

PDF Available

Quick Actions

Read Full Paper

Publication Info

DOI

10.1007/s00125-007-0738-5

Language

English

Topic

Liver Disease Diagnosis and Treatment

Keywords

Insulin resistance, Endocrinology, Fatty liver, Internal medicine, Biology, Downregulation and upregulation, Transcription factor, Glucose homeostasis, Insulin, Gene, Biochemistry, Medicine, Disease

Published

July 5, 2007

Citations

105 citations

FWCI

6.07

External Resources

DOI Link OpenAlex

Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice

Quick Actions

Publication Info

External Resources

Suggested Papers

Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer

A randomised controlled trial to compare the effectiveness of icepacks and Epifoam with cooling maternity gel pads at alleviating postnatal perineal trauma

Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2

Suggested Papers

Suggested Papers

Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer

A randomised controlled trial to compare the effectiveness of icepacks and Epifoam with cooling maternity gel pads at alleviating postnatal perineal trauma

Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2